Answers are grounded in this paper and cite their sources.
PURPOSE: To evaluate the safety and efficacy of treatment of severe infectious corneal ulcers with hypoosmolar riboflavin solution and UV-A collagen cross-linking (CXL) without deepithelizing the cornea. METHODS: Four eyes of 3 patients with severe keratitis and associated corneal melting, were treated with a new protocol of corneal CXL for infectious keratitis, named cross-linking window absorption (CXL-WA). CXL-WA was performed when the infection did not respond to systemic and topical antibiotic therapy. The protocol entails the use of hypoosmolar riboflavin before the irradiation with UV-A, and the penetration is obtained through the epithelial defect overlying the ulcer. RESULTS: In all cases, CXL halted the progression of the ulcer. After a minimum follow-up of 3 months, none of the patients had recurrence of the infection. CONCLUSION: CXL-WA is a promising technique of treatment of infectious corneal ulcers, delaying or preventing more invasive approaches.
No takes yet. Share an insight, caveat, or question.
Rosetta et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: